Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells
Authors:
- 1 April 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (4) , 619-625
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionChemico-Biological Interactions, 1988
- Decreased cisplatin uptake by resistant L1210 leukemia cellsCancer Letters, 1987
- Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patientInternational Journal of Cancer, 1987
- In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assayCancer Chemotherapy and Pharmacology, 1985
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- CisplatinAnnals of Internal Medicine, 1984
- Carrier-dependent and carrier-independent transport of anti-cancer alkylating agentsNature, 1981
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A method using 3-O-methyl-D-glucose and phloretin for the determination of intracellular water space of cells in monolayer cultureAnalytical Biochemistry, 1975